Actinogen Medical
(ASX) ACW
Actinogen Medical Financials at a Glance
Market Cap
$136.48M
Revenue (TTM)
$14.51M
Net Income (TTM)
$27.57M
EPS (TTM)
$-0.01
P/E Ratio
-6.79
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$0.04
Volume
1,517,308
Open
$0.04
Price
$0.04
Volume
1,517,308
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.02 - $0.07
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$0.04
Volume
1,517,308
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.02 - $0.07
ACW News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Actinogen Medical
Industry
Biotechnology
Sector
Health CareCEO
Steven G. Gourlay, MD, PhD
Website
www.actinogen.com.auHeadquarters
Sydney, NSW 2000, AU
ACW Financials
Key Financial Metrics (TTM)
Gross Margin
96%
Operating Margin
-4%
Net Income Margin
-3%
Return on Equity
-111%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-14.73%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$136.48M
Shares Outstanding
3.59B
Volume
1.52M
Short Interest
0.00%
Avg. Volume
3.96M
Financials (TTM)
Gross Profit
$5.49M
Operating Income
$14.93M
EBITDA
$15.01M
Operating Cash Flow
$7.56M
Capital Expenditure
$38.02K
Free Cash Flow
$7.59M
Cash & ST Invst.
$16.50M
Total Debt
$3.26M
Actinogen Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$210.68K
-130.2%
Gross Margin
0.00%
N/A
Market Cap
$136.48M
N/A
Market Cap/Employee
$22.75M
N/A
Employees
6
N/A
Net Income
$11.35M
+1.8%
EBITDA
$13.07M
-6.8%
Quarterly Fundamentals
Net Cash
$6.17M
-46.1%
Accounts Receivable
$2.18M
+544.6%
Inventory
$0.00
N/A
Long Term Debt
$284.84K
N/A
Short Term Debt
$81.47K
-8.7%
Return on Assets
-1.69%
N/A
Return on Invested Capital
-2.36%
N/A
Free Cash Flow
$7.12M
-9.7%
Operating Cash Flow
$7.12M
-9.7%